ERAP1 and colorectal cancer: The treatment interaction analysis for certain SNPs such as for ERAP1 and CIITA showed interaction with oxaliplatin, which has been shown to cause immunogenic cell death in colorectal cancer cells [25,26] and upregulate MHC class I via the nuclear factor-kappa B (NF-κB) pathway [27].